Catalyst Wire Dossier Catalyst Wire Dossier

recombinant HPV bivalent vaccine

· Xiamen Innovax Biotech Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant HPV bivalent vaccine, covering 2022-06-29 to 2022-06-29. Get the full timeline:

Most recent: Clinical Trial Update: Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female [Phase 4]

See pricing